| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |